Lone Star Value Management’s Enzo Biochem ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-575,000
Closed -$2.62M – 18
2016
Q1
$2.62M Sell
575,000
-25,000
-4% -$111K 6.3% 4
2015
Q4
$2.7M Sell
600,000
-150,000
-20% -$633K 5% 8
2015
Q3
$2.38M Buy
750,000
+729,000
+3,471% +$2.21M 4.53% 9
2015
Q2
$64K Hold
21,000
– – 0.09% 19

Other funds holding ENZ

Lone Star Value Management's ENZ Position: Q2 2016 in Review

Lone Star Value Management sold out of Enzo Biochem (ENZ) in Q2 2016, closing a stake of 575,000 shares — an estimated $2.62M sold.

Lone Star Value Management first reported a position in ENZ in Q2 2015 and held it in 4 quarters. The position peaked at $2.7M in Q4 2015. 104 funds tracked by Wall St. Rank hold ENZ as of Q2 2016.

  • Lone Star Value Management reported no remaining Enzo Biochem position as of Q2 2016 after selling out during the quarter.
  • Lone Star Value Management sold 575,000 Enzo Biochem shares in Q2 2016, an estimated $2.62M.
  • Lone Star Value Management first reported a position in Enzo Biochem in Q2 2015 and held it in 4 quarters.
  • Lone Star Value Management's Enzo Biochem position peaked at $2.7M in Q4 2015.
  • 104 funds tracked by Wall St. Rank held Enzo Biochem as of Q2 2016.

Based on Lone Star Value Management's 13F filing for Q2 2016, filed 15 Aug 2016.